List of questions

If one resolved all the Beta Lactamase variations in a given infection could one reintroduce these 80 Beta Lactam antibiotics presently in the dustbin as presently it is too risky to administer for fear resistance is present in a given infection.

My firm has an unusual fast DNA methodology that produces unusual data that essentially resolves all of the critical Beta Lactamase variations. This allows one select the correct Beta Lactamase inhibitor. Once this is known for a given infection then choosing the right combination of inhibitor and Beta Lactam is simple.

Funding for research

Funding for research is an important part of the process. The challenge that we have is being able to provide the information and costs of the samples in advance to allow this to be included in the funding application. How can we work together to improve this

Timescale for receipt of samples

I am aware that the academics have the ability to source tissue from the NHS Research Biorepositores and Tissue Services, but provision is subject to demand and availability of tissue. How can we increase acceptability that a virtual biobank can be considered an alternative if NHS research cannot supply. We can supply high quality samples at short notice

How do we increase the collaboration between research and Commercial biobanks

This needs to be made more acceptable. Virtual biobanks can make the life of the researcher much easier by undertaking the hassle of identifying suitable samples and logistics. This then allows the academic to work on the research.

How do we increase interaction wth University Procurement

It is difficult to interact and meet with the University Procurement, how do we make this more interactive and speed up the process for the academics in purchasing the much needed samples for their research purposes